Dechra Pharmaceuticals PLC — Board/Management Information 2015

Nov 11, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3127F

Dechra Pharmaceuticals PLC

11 November 2015

11 November 2015

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company") 

Director's Declaration

In accordance with Listing Rule 9.6.14(2) Dechra announces that Dr Christopher Richards, Non-Executive Director of Dechra, is to be appointed as a

Non-Executive Director of Nanoco Group plc with effect from 11 November 2015.

For further information:

Suzana Cross, Company Secretary  and General Counsel 

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNGIBDBLDBBGUB